Dr. Harvey Goldberg is a Bay Shore, New York based physiatrist who is specialized in Pain Management (PM&R). Active license number of Dr. Harvey Goldberg as Pain Management (PM&R) is 160579 in New York.
Dr. Harvey Goldberg provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
Complete Profile:
Dr. Harvey Goldberg speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Pain Management (PM&R)
Credentials:
M.D.
Gender:
Male
Practice Address:
260 W Main St, Suite 12, Bay Shore, New York, 11706-8322
Phone:
631-969-1248
Fax:
631-968-4383
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1699823781
NPI Enumeration Date:
08 Jan, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Harvey Goldberg are as mentioned below.
License Number
Specialization
State
Status
160579
Pain Management
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
905 Manor Ln, Bay Shore, New York
Zip:
11706-7526
Phone Number:
631-969-1248
Fax Number:
631-968-4383
Patients can reach Dr. Harvey Goldberg at 260 W Main St, Suite 12, Bay Shore, New York or can call to book an appointment on 631-969-1248. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.